
The European bioeconomy takes another step forward thanks to the successful initial public offering of Avantium which raised €103 M on Euronext Amsterdam and Euronext Bruxelles. Sofinnova Capital VI – Sofinnova Partners states – remains the main shareholder after the IPO. The initial public offering was multiple times oversubscribed.